Katharine Knobil - 14 Sep 2022 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Director
Signature
/s/ Mike Ouimette, attorney-in-fact
Issuer symbol
PLRX
Transactions as of
14 Sep 2022
Net transactions value
$0
Form type
4
Filing time
16 Sep 2022, 18:08:40 UTC
Previous filing
26 May 2022
Next filing
08 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 14 Sep 2022 Common Stock 30,000 $24.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of September 14, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.